Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stem cell
Biotech
Astellas closes stem cell unit’s Seattle site, layoffs incoming
Astellas is preparing to close its Seattle site for its stem cell therapy unit, with around 55 employees set to be affected.
James Waldron
Apr 14, 2026 10:45am
Preclinical stem cell biotech takes SPAC route to Nasdaq
Feb 4, 2026 10:15am
ReNeuron leaving AIM exchange after missing fundraising goal
Aug 30, 2024 10:30am
Sickle cell gene therapy process may cause cancerous mutations
Nov 20, 2023 9:10am
Omeros saddles up for 2nd charge at transplant drug approval
Mar 14, 2023 9:30am
MaaT wraps up microbiome trial early to power into phase 2/3
Jan 24, 2022 7:20am
